伴随医学治疗出现的骨质流失。 - Suppr

Suppr

超能文献

Bone loss accompanying medical therapies.

作者信息

Dawson-Hughes B

出版信息

N Engl J Med. 2001 Sep 27;345(13):989-91. doi: 10.1056/NEJM200109273451310.

DOI:10.1056/NEJM200109273451310

PMID:11575293

Abstract

摘要

相似文献

Bone loss accompanying medical therapies.伴随医学治疗出现的骨质流失。

N Engl J Med. 2001 Sep 27;345(13):989-91. doi: 10.1056/NEJM200109273451310.

Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer.帕米膦酸盐预防前列腺癌雄激素剥夺治疗期间的骨质流失。

N Engl J Med. 2001 Sep 27;345(13):948-55. doi: 10.1056/NEJMoa010845.

Re: Diethylstilbesterol revisited: androgen deprivation, osteoporosis an prostate cancer.

J Urol. 2002 Jul;168(1):201; author reply 201.

[Bone loss induced by GnRH agonist treatment].[促性腺激素释放激素激动剂治疗引起的骨质流失]

Nihon Rinsho. 2004 Feb;62 Suppl 2:702-5.

Patient quality of life safeguarding: the primary aim in nonmetastatic prostate cancer patients.患者生活质量保障：非转移性前列腺癌患者的首要目标。

J Clin Oncol. 2007 Aug 1;25(22):3385; author reply 3385-6. doi: 10.1200/JCO.2007.12.3125.

Effects of gonadotropin-releasing hormone agonists on bone metabolism markers and bone mineral density in patients with prostate cancer.促性腺激素释放激素激动剂对前列腺癌患者骨代谢标志物及骨密度的影响。

Urology. 2004 Jul;64(1):128-31. doi: 10.1016/j.urology.2004.03.012.

Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.唑来膦酸预防前列腺癌男性患者促性腺激素释放激素激动剂所致骨质流失的年度随机对照试验。

J Clin Oncol. 2007 Mar 20;25(9):1038-42. doi: 10.1200/JCO.2006.07.3361.

[Bone fracture receiving LH-RH agonists for prostatic cancer].[因前列腺癌接受促黄体生成素释放激素激动剂治疗导致的骨折]

Nihon Hinyokika Gakkai Zasshi. 2000 Jun;91(6):542-6. doi: 10.5980/jpnjurol1989.91.542.

Bisphosphonates effective in preventing bone complications associated with androgen deprivation therapy.双膦酸盐在预防与雄激素剥夺治疗相关的骨并发症方面有效。

J Support Oncol. 2006 Feb;4(2):99-100.

[Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer].[骨骼与男性健康。前列腺癌的激素治疗与骨质流失]

Clin Calcium. 2010 Feb;20(2):175-81.

引用本文的文献

Asthma and therapeutics: inhaled corticosteroids, corticosteroid osteoporosis, and the risk of fracture in chronic asthma.哮喘与治疗：吸入性皮质类固醇、皮质类固醇性骨质疏松症与慢性哮喘骨折风险。

Allergy Asthma Clin Immunol. 2005 Mar 15;1(1):28-33. doi: 10.1186/1710-1492-1-1-28.

New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition.新见解：围绝经期卵泡刺激素升高与骨质流失

Curr Rheumatol Rep. 2009 Jul;11(3):191-5. doi: 10.1007/s11926-009-0026-0.

[Therapy of hormone-refractory prostate cancer].

Urologe A. 2005 Dec;44(12):1481-94; quiz 1495. doi: 10.1007/s00120-005-0980-8.

[Treatment options for hormone-refractory prostate cancer].[激素难治性前列腺癌的治疗选择]

Urologe A. 2005 Nov;44(11):1303-4, 1306-14. doi: 10.1007/s00120-005-0928-z.

[The aftercare principle for metastasizing prostate cancer. Few diagnostics, much support].[转移性前列腺癌的术后护理原则。少诊断，多支持]

Urologe A. 2005 Sep;44(9):1009-12, 1014-7. doi: 10.1007/s00120-005-0885-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验